Litcius/Paper detail

The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines

Daan J.A. Crommelin, David B. Volkin, Karin H. Hoogendoorn, A. S. Lubiniecki, Wim Jiskoot

2020Journal of Pharmaceutical Sciences60 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)PandemicViral vectorSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyVector (molecular biology)2019-20 coronavirus outbreakViral replicationComputer scienceMedicineBiologyVirusInfectious disease (medical specialty)OutbreakRecombinant DNABiochemistryGeneDiseasePathologySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyProtein purification and stability
The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines | Litcius